Home » Stocks » RCEL

Avita Therapeutics, Inc. (RCEL)

Stock Price: $22.71 USD 1.00 (4.61%)
Updated Jan 15, 2021 12:35 PM EST - Market open
Market Cap 469.44M
Revenue (ttm) 16.07M
Net Income (ttm) n/a
Shares Out 21.50M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $22.71
Previous Close $21.71
Change ($) 1.00
Change (%) 4.61%
Day's Open 22.67
Day's Range 22.66 - 23.78
Day's Volume 85,989
52-Week Range 17.55 - 30.54

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 2 weeks ago

VALENCIA, Calif. and MELBOURNE, Australia, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializin...

GlobeNewsWire - 1 month ago

VALENCIA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platfo...

Seeking Alpha - 1 month ago

AVITA's existing FDA-approved product is growing to become the standard of care in a $200 million market. The COVID-19 pandemic has been particularly disruptive for AVITA.

Seeking Alpha - 2 months ago

AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha - 2 months ago

AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry On Q3 2020 Results - Quick Version Earnings Call Transcript.

GlobeNewsWire - 2 months ago

VALENCIA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platfo...

GlobeNewsWire - 2 months ago

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and...

GlobeNewsWire - 2 months ago

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercia...

GlobeNewsWire - 2 months ago

VALENCIA, Calif, and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercial...

GlobeNewsWire - 2 months ago

VALENCIA, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platfo...

GlobeNewsWire - 2 months ago

VALENCIA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platfo...

GlobeNewsWire - 2 months ago

VALENCIA, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platfo...

GlobeNewsWire - 2 months ago

VALENCIA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platfo...

Business Wire - 5 months ago

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Therapeutics, Inc.

The Motley Fool - 8 months ago

These modern healthcare stocks could take care of you very well.

Other stocks mentioned: CHE
The Motley Fool - 10 months ago

Find a glittering gem before the stock price takes off.

Other stocks mentioned: GLDD
Seeking Alpha - 1 year ago

Spectacular performer in 2019 still has a long way to go.

The Motley Fool - 1 year ago

Today's risky stocks could be tomorrow's blockbuster investments.

Other stocks mentioned: BIDU, Z, ZG
The Motley Fool - 1 year ago

Seven biotechs led the way.

Other stocks mentioned: ARQL, AXSM, CNST, DRRX, EVER, ISEE, KOD, PRVB, SSI
Zacks Investment Research - 1 year ago

Though international markets trailed the U.S. market in 2019, there are hidden gems that crushed the S&P 500 this year on stock-specific strength.

Other stocks mentioned: AVDL, EDU, SBGL, VIPS

About RCEL

AVITA Medical operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to ... [Read more...]

Industry
Medical Devices
CEO
Dr. Michael S. Perry D.V.M., DVM, Ph.D., FACVPT
Employees
98
Stock Exchange
NASDAQ
Ticker Symbol
RCEL
Full Company Profile

Financial Performance

In 2020, RCEL's revenue was 18.19 million, an increase of 59.62% compared to the previous year's 11.40 million. Losses were -42.03 million, 67.4% more than in 2019.

Financial numbers in millions AUD.
Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for RCEL stock is "Strong Buy." The 12-month stock price forecast is 45.20, which is an increase of 99.03% from the latest price.

Price Target
$45.20
(99.03% upside)
Analyst Consensus: Strong Buy